Management Strategies For High Risk Stroke Patients Are Poor In A Majority Of Cases
Posted on: Monday, 8 June 2009, 14:38 CDT
A majority of high-risk stroke patients are less likely to meet clinical treatment targets to prevent repeat stroke or heart attacks compared to those with heart disease, suggesting the need to examine new therapeutic strategies, according to a study led by St. Michael's Hospital neurologist Dr. Gustavo Saposnik. What's more, medical procedures or ongoing specialty care may improve patients' awareness and consequent treatment success.The study, an analysis of 4,933 outpatients with a past history of heart attack and cerebrovascular disease (stroke) across Canada, found:
- About 30 per cent of patients with heart disease achieved target blood pressure and LDL-cholesterol levels
- Only 20 per cent of stroke patients met target blood pressure and LDL-cholesterol levels . (At the time of the study, Canadian guidelines recommended a LDL-cholesterol target of less than 2.5 mmol/L and a blood pressure target of less than 140/90 mm Hg or less than 130/80 mm Hg for diabetic patients).
- Among stroke patients, women were also less likely to meet the targets despite a similar medical history of treatment with antihypertensive and LDL-cholesterol-lowering therapies.
According to the study, inappropriate drug or dose selection, lack of aggressive management, patient nonadherence or limited drug efficacy may pose barriers to poor treatment success. The researchers suggest differences in the emphasis of recommended targets between heart and stroke prevention guidelines may account for the gap.
"Despite the effectiveness and benefits of antihypertensive and lipid-lowering therapies, management of heart disease and stroke patients remains poor," said St. Michael Hospital cardiologist Dr. Shaun Goodman, who created the database used in the study. "A significant proportion of patients who failed to meet guidelines within our study were stroke patients and women. Quality improvement strategies should target these patient subgroups so that we can develop benchmarks that can lead to improved clinical practice."
-----------
On The Net:
St. Michael's Hospital
Related Articles
- New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
- Ocera Therapeutics Presents Data on AST-120 in Patients With Hepatic Encephalopathy at the European Association for the Study of Liver Disease Annual Meeting
- New Study Demonstrates Colesevelam HCl Lowers Both A1C And LDL Cholesterol in Patients With Uncontrolled Type 2 Diabetes Mellitus on Metformin-Based Regimen
- MultiVu Video Feed: Intensive Lipitor Therapy Cuts The Risk of Hospitalizations Due to Heart Failure in Patients With Coronary Heart Disease, New Analysis Shows
- Ultra-Low LDL Cholesterol May Not Help
- 'Bad' LDL Cholesterol May Benefit Elderly
- Role of Cholesterol Lowering Drugs in Heart Failure Patients Evaluated in Yale Medical Center's Heart Study
- Lipitor OK'D to Prevent Strokes in Diabetics Study Shows Those Taking the Cholesterol-Lowering Drug Had Fewer Strokes.
- New Analysis in Patients With Type 2 Diabetes From Trial With VYTORIN-TM- -Ezetimibe/Simvastatin- Presented at ADA; Consistent With Overall Study Which Showed Superior LDL Cholesterol Reduction With VYTORIN Versus Lipitor
- A CHANGE OF HEART: How the Framingham Heart Study Helped Unravel the Mysteries of Cardiovascular Disease
User Comments (0)

RSS Feeds